Results 61 to 70 of about 11,249 (166)

Gynecomastia during imatinib mesylate treatment for gastrointestinal stromal tumor: a rare adverse event

BMC Gastroenterology, 2011
Background Imatinib mesylate has been the standard therapeutic treatment for chronic myeloid leukemia, advanced and metastatic gastrointestinal stromal tumor (GIST). It is well tolerated with mild adverse effects.
Yan ZhongShu, Liao GuoQing, Liu HeLi
doaj   +1 more source

Risk of gynecomastia and breast cancer associated with the use of 5-alpha reductase inhibitors for benign prostatic hyperplasia

Clinical Epidemiology, 2017
Katrina Wilcox Hagberg,1 Hozefa A Divan,2 Shona C Fang,2 J Curtis Nickel,3 Susan S Jick1 1Boston Collaborative Drug Surveillance Program, Boston University School of Public Health, Lexington, 2New England Research Institutes, Inc., Watertown, MA, USA ...
Hagberg KW, Divan HA, Fang SC, Nickel JC, Jick SS   +4 more
doaj  

Psychological Resilience, Body Appreciation, and Associations with Anxiety and Depression in Pubertal Gynecomastia: A Case-Controlled Study

Neuropsychiatric Investigation
Objective: Pubertal gynecomastia may have adverse psychosocial consequences, yet the influence of psychological resilience has been insufficiently explored.
Yavuz Meral, Mehmet Sezgin, Yavuz Özer
doaj   +1 more source

Male Gynecomastia [PDF]

Mayo Clinic Proceedings, 2009
Bridgett A, Haynes, Farouk, Mookadam
openaire   +2 more sources

Approach to the patient with Gynecomastia: Beyond the basics

Amrita Journal of Medicine
Gynecomastia is a benign enlargement of the glandular tissue in the male breast caused by an increase in the ratio of estrogen to androgen activity. It can be classified as pathologic (resulting from medications or conditions such as androgen deficiency,
Aditya Sharma, Vivek Srivastava, Arvind Pratap, Mumtaz Ahmad Ansari   +3 more
doaj   +1 more source

The incidence of pubertal gynecomastia in boys living in the Ankara region

The Turkish Journal of Pediatrics, 1989
The incidence of pubertal gynecomastia was determined in 646 Turkish boys in Ankara. A marked increase in the incidence was observed at Pubertal Stage 4 (60.2%) and age 14 years (61.1%).
H Güvenç, M Yurdakök, E Kinik, A Büyükgebiz   +3 more
doaj  

Pubertal gynecomastia incidence among 530,000 boys: a cross sectional population based study

Frontiers in Pediatrics
BackgroundAdolescent gynecomastia, a benign proliferation of male breast tissue, can lead to psychological issues during adolescence. The prevalence varies widely (4%−69%). The incidence peaks are during neonatal, pubertal, and senescent periods.
Ori Berger, Tzipi Hornik-Lurie, Ran Talisman   +2 more
doaj   +1 more source

Gynecomastia [PDF]

Mayo Clinic Proceedings, 2010
ROSSATO, MARCO, Sogaro M, VETTOR, ROBERTO   +2 more
  +6 more sources

Available techniques to minimize scars in surgical management of gynecomastia – a comprehensive review

JPRAS Open
Objective: Gynecomastia and lipomastia are benign proliferations of the male breast affecting 32–65% of men. Numerous surgical procedures often result in stigmatizing scars when it comes to skin resection.
G. Frigerio, A. Serre, P.E. Engels, D.F. Kalbermatten, D. André-Lévigne   +4 more
doaj   +1 more source

Deep Learning-Based Drug Compounds Discovery for Gynecomastia

Biomedicines
Background: Gynecomastia, caused by an estrogen–testosterone imbalance, affects males across various age groups. With unclear mechanisms and no approved drugs, the condition underscores the need for efficient, innovative treatment strategies.
Yeheng Lu, Byeong Seop Kim, Junhao Zeng, Zhiwei Chen, Mengyu Zhu, Yuxi Tang, Yuyan Pan   +6 more
doaj   +1 more source